Bioinformatics and Digital Health including AI

Developments in bioinformatics, and in particular AI, are fuelling important advances in the biotech and digital health space. The wealth of genetic and other information that can now be gleaned from experiments combined with the increasing power of AI underpins many commercially important digital health inventions. These important bioinformatics advances, for example, in AI-based cancer diagnosis or in silico drug design, can be patent protected to provide commercially useful protection to maintain your business’ position at the forefront.

HGF works on these advances for our clients which include global corporations, including pharma, SMEs, and prestigious universities. We advise on patent protection and trade secret protection, developing an IP strategy that provides the best protection for their bioinformatics and AI inventions.

We have worked on, for example, next generation sequencing analyses; AI-based cancer diagnostics (based on images or sequencing data); AI 3D structure analysis; small molecule in silico drug design; microbiome sequencing; AI-based patient groupings for personalized medicine; AI microbe detection and AI-based immunotherapy drug design.

Bioinformatics and AI inventions like these require a depth of experience in the crossover area between life sciences, electronics, and maths. Because of this, we have built a dedicated team of attorneys who have experience in this crossover area: life sciences attorneys with computational biology and AI backgrounds; as well as electronics attorneys and mathematics attorneys with further degrees or patent experience in life sciences.  The members of our team have drafted and successfully prosecuted bioinformatics and AI applications; defended key bioinformatics patents in opposition; and provided FTO analyses.

Trade secret protection is also key to digital health due to the wealth of value in the databases typical of AI inventions. Our team therefore also includes IP solicitors who, alongside our experienced attorneys, can put trade secret protection in place.

Latest updates

What's Next for CAR Cell Therapy?

The first generation CAR T cell was discovered in 1993 when the variable region of an antibody was fused to the constant regions of a T cell receptor.  Now, 20 …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 23rd - 24th April 2024

Microbiome & Probiotic R&D & Business Collaboration Forum: Europe

The 12th Microbiome & Probiotics R&D and Business Forum will take place from the 23rd-24th April at the Postillion Convention Centre in the Hague, Netherlands. This world-renowned event will see …

Event details

IAM Patent 1000 2023

IAM Patent 1000 the world’s leading patent professionals 2023 guide has now been published and we are delighted to have 31 attorneys recognised as world-class individuals in the guide. The …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article
Event - 8th - 9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our bioinformatics specialists.